Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · IEX Real-Time Price · USD
17.07
-0.64 (-3.61%)
At close: Jul 26, 2024, 4:00 PM
16.95
-0.12 (-0.70%)
After-hours: Jul 26, 2024, 6:59 PM EDT
Pulse Biosciences Market Cap
Pulse Biosciences has a market cap or net worth of $1.05 billion as of July 26, 2024. Its market cap has increased by 292.16% in one year.
Market Cap
1.05B
Enterprise Value
1.00B
1-Year Change
292.16%
Ranking
Category
Stock Price
$17.07
Market Cap Chart
Since May 18, 2016, Pulse Biosciences's market cap has increased from $52.40M to $1.05B, an increase of 1,894.50%. That is a compound annual growth rate of 44.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 978.00M | 45.30% |
| Dec 29, 2023 | 673.10M | 552.86% |
| Dec 30, 2022 | 103.10M | -76.50% |
| Dec 31, 2021 | 438.80M | -27.42% |
| Dec 31, 2020 | 604.60M | 116.86% |
| Dec 31, 2019 | 278.80M | 43.19% |
| Dec 31, 2018 | 194.70M | -49.52% |
| Dec 29, 2017 | 385.70M | 345.90% |
| Dec 30, 2016 | 86.50M | 65.08% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtriCure | 1.16B |
| Autolus Therapeutics | 1.14B |
| Arcutis Biotherapeutics | 1.13B |
| Enliven Therapeutics | 1.13B |
| Collegium Pharmaceutical | 1.12B |
| Innoviva | 1.10B |
| Tyra Biosciences | 1.10B |
| Maravai LifeSciences Holdings | 1.10B |